Friday | 21 November, 2008
Stories about: Rockeby Biomed
- +
Flu's up for Rockeby 24/07/2008 15:28:01
Rockeby receives $252,000 worth of orders for bird flu test - +
Rockeby to supply avian flu tests in Turkey, aims to raise $1.73m 28/02/2006 12:49:32
Singapore-based Rockeby Biomed (ASX:RBY) has signed an exclusive deal to supply its avian flu kits to the Turkish Poultry Industry, an organisation which represents 90 per cent of the poultry industry in Turkey. - +
Over the counter, into the black 07/02/2006 14:12:01
Singapore-based, ASX-listed Rockeby Biomed (ASX:RBY) has changed its focus and managing director Dr Sze Wee Tan has a positive outlook for this year. Helen Schuller reports. - +
Rockeby bets on bird flu tests for turnaround 20/12/2005 13:10:16
ASX-listed, Singapore-based Rockeby Biomed (ASX:RBY) has said it might break even in the year ending June 2007, thanks to its new bird flu test kits. - +
Australian biotech hears the tiger's roar 21/11/2005 10:47:51
David Binning finds a wealth of opportunities for Australian integration with other Asian biotech industries. - +
Setback for Rockeby in US 14/11/2005 14:38:25
After a meeting with officials of the US Food and Drug Administration, fungal infection diagnostics specialist Rockeby Biomed (ASX:RBY) has mothballed its attempt to register its point-of-care CanDia5 test for vaginal thrush infection (candidiasis) for use in the US. - +
Rockeby shares soar after bird flu test deal 08/11/2005 14:03:54
Shares in Rockeby Biomed (ASX:RBY) quadrupled in value today after the company announced it has signed a deal with Thailand-based Pacific Biotech for the exclusive marketing and distribution rights in Europe, the Asia-Pacific and South Africa to two tests for avian flu. - +
In brief: Living Cell Technologies, Phosphagenics, Rockeby, Antisense, Prima, Proteome Systems 14/10/2005 10:49:29
Living Cell Technologies (ASX:LCT) has appointed US based neuroscientist Dr Dwaine F Emerich as chief scientific officer of LCT BioPharma. He has been LCT's US vice-president of research since 2003, joining the company from Sertoli Technologies. - +
Rockeby biomed raises $1 million 29/07/2005 13:48:08
Singapore's Rockeby biomed (ASX:RBY) has raised just over AUD$1 million in a non-renounceable one-for-one share rights issue to shareholders, approximately $786,000 less than the AUD$1.78 million it hoped for. - +
Rockeby granted US patent for candida detection kit 14/07/2005 13:25:40
Rockeby biomed (ASX:RBY) has been awarded an additional US patent over its SysCan3 Hospital Test Kit for use in the diagnosis of candida infections such as systemic candidiasis and thrush. - +
In brief: Rockeby, GTG, PharmAust, Mimotopes, Solbec 04/07/2005 13:31:55
Rockeby Biomed (ASX:RBY) has lodged a prospectus to raise AUD$1.78 million through a non-renounceable one-for-one share rights issue. The issue price for each share is $0.01 and the company expects the capital to see it through to the end of financial year 2006.
Additional Resources
Newsletter Subscription
Australian Life Scientist Member Login
Kingston Technology Launches HyperX T1 Series Memory 2008-11-19 11:00:00+11
Erase your discs with Lite-On SmartErase 2008-11-12 14:00:00+11
Antarctica NZ to Optimise Satellite Communications over the WAN with Expand Networks 2008-11-11 08:22:00+11
Kingston Technology Launches HyperX DDR3 2GHz Triple-Channel Memory in Support of Intel Core i7, X58 Platforms 2008-11-06 16:40:00+11
WD TV™ HD Media Player brings Digital Media Collections to the Big Screen 2008-11-05 11:00:00+11
Sponsored Links
Subscribe to Australian Life Scientist
Australian Life Scientist is Australia's leading magazine for the life sciences sector.
